Related Experiment Video
Updated: Jan 8, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Neurosymbolic Digital Twin for Cardiovascular Disease Prediction and Personalized Modeling
Abstract:
Cardiovascular prediction and therapy planning require high diagnostic fidelity, identifiable causal structure, patient-specific adaptation, and quantifiable privacy. NeuroTwin is a neurosymbolic digital twin that integrates four computational modules into a unified clinical decision framework. The adaptive diffusion transformer (ADViT) performs modality-specific denoising of ECG and PCG signals, followed by patch-level feature encoding and cross-modal fusion that preserves temporal-spectral structure. The symbolic causal discovery network (SCDN) constructs a sparse directed acyclic graph through a differentiable acyclicity constraint and converts stable edges into executable rules. The neural federated digital twin (NFDT) performs distributed optimization with differentially private Gaussian aggregation and incorporates online patient-state updates for personalized modeling under heterogeneous institutional data distributions. A hierarchical meta-reinforcement learner (HMRL) governs treatment recommendations through a bi-level policy that balances symptom reduction, adverse-effect mitigation, and longitudinal stability. NeuroTwin achieves 98.5% diagnostic precision, 96.2% success in treatment optimization, a 0.942 causal explainability score and a 0.032 privacy leakage rate.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Model Approaches for Pharmacokinetic Data: Physiological Models

